Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $13.22 Analyst target: $16.17 Upside: 22.31%
InMode Ltd. designs, develops, manufactures and markets minimally invasive aesthetic medical products based on its proprietary RF-assisted lipolysis and deep subdermal fractional RF technologies. The company is headquartered in Yokneam, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.